Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000112193 | SCV000300026 | pathogenic | Breast-ovarian cancer, familial, susceptibility to, 1 | 2016-09-08 | reviewed by expert panel | curation | Variant allele predicted to encode a truncated non-functional protein. |
Labcorp Genetics |
RCV002514559 | SCV003236939 | pathogenic | Hereditary breast ovarian cancer syndrome | 2022-12-08 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ala1279Glyfs*8) in the BRCA1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BRCA1 are known to be pathogenic (PMID: 20104584). This variant has not been reported in the literature in individuals affected with BRCA1-related conditions. This variant is also known as 3949insC. ClinVar contains an entry for this variant (Variation ID: 125655). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000112193 | SCV004216917 | pathogenic | Breast-ovarian cancer, familial, susceptibility to, 1 | 2022-09-02 | criteria provided, single submitter | clinical testing | |
Breast Cancer Information Core |
RCV000112193 | SCV000144889 | pathogenic | Breast-ovarian cancer, familial, susceptibility to, 1 | 2002-06-20 | no assertion criteria provided | clinical testing |